China Health Group Ltd (HKG: 0673) announced the signing of a framework agreement with compatriot firm Wuhan Mingcheng Wanda Pharmaceutical Co., Ltd, seeking to carry out close collaboration on the comprehensive distribution of medical and big health products. The two sides are working on specific transaction terms, and an official agreement will be written up at an appropriate time.
Investment and Distribution Platform
China Health is set to invest in Mingcheng Wanda Pharma’s business, and jointly create a comprehensive international distribution platform including brick-and-mortar and e-commerce.
Company Background and Services
China Health is focused on the distribution of medical devices and consumables and the provision of related services, hospital operation, management services, and commercial factoring. Mingcheng Wanda, covering western medicine, traditional Chinese medicine, health care products, medical devices, medical equipment, medical testing, and others, provides integrated services such as procurement, marketing, logistics, distribution, Internet, and physical expansion.-Fineline Info & Tech
